|
|
|
|
pmid:28594456
|
|
|
|
|
pmid:28233648
|
|
|
|
|
pmid:28314870
|
|
|
|
|
pmid:24125633
|
|
|
|
|
pmid:29129690
|
|
|
|
|
pmid:28450161
|
|
|
|
|
pmid:28044940
|
|
|
|
|
pmid:27394002
|
|
|
|
|
pmid:27220072
|
|
|
|
|
pmid:26475687
|
|
|
|
|
pmid:25497898
|
|
|
|
|
pmid:25240714
|
|
|
|
|
pmid:27325307
|
|
|
|
|
pmid:27890582
|
|
|
|
|
pmid:
|
Belanger JT |
Perillyl alcohol: applications in oncology. |
1998 |
Altern Med Rev |
pmid:9855569
|
Karlson J et al. |
Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of action. |
1996 |
Anticancer Drugs |
pmid:8826611
|
Yeruva L et al. |
Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin. |
2010 |
Anticancer Drugs |
pmid:19820395
|
Samaila D et al. |
Monoterpenes enhanced the sensitivity of head and neck cancer cells to radiation treatment in vitro. |
2004 Sep-Oct |
Anticancer Res. |
pmid:15517920
|
DA Fonseca CO et al. |
Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation. |
2013 |
Anticancer Res. |
pmid:24324108
|
Burke YD et al. |
Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention. |
2002 Nov-Dec |
Anticancer Res. |
pmid:12530055
|
Stayrook KR et al. |
Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancreatic cells. |
1998 Mar-Apr |
Anticancer Res. |
pmid:9615726
|
d'Alessio PA et al. |
Skin repair properties of d-Limonene and perillyl alcohol in murine models. |
2014 |
Antiinflamm Antiallergy Agents Med Chem |
pmid:24160248
|
van Beilen JB et al. |
Biocatalytic production of perillyl alcohol from limonene by using a novel Mycobacterium sp. cytochrome P450 alkane hydroxylase expressed in Pseudomonas putida. |
2005 |
Appl. Environ. Microbiol. |
pmid:15811996
|
Peffley DM et al. |
Perillyl alcohol and genistein differentially regulate PKB/Akt and 4E-BP1 phosphorylation as well as eIF4E/eIF4G interactions in human tumor cells. |
2007 |
Arch. Biochem. Biophys. |
pmid:17601486
|
da Fonseca CO et al. |
Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol. |
2008 Jul-Aug |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:18726148
|
D'Alincourt Salazar M et al. |
Intranasal administration of perillyl alcohol activates peripheral and bronchus-associated immune system in vivo. |
2014 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:24257817
|
Imamura M et al. |
Perillyl alcohol suppresses antigen-induced immune responses in the lung. |
2014 |
Biochem. Biophys. Res. Commun. |
pmid:24309112
|
Ren Z et al. |
Inhibition of type I and type II geranylgeranyl-protein transferases by the monoterpene perillyl alcohol in NIH3T3 cells. |
1997 |
Biochem. Pharmacol. |
pmid:9296357
|
Sundin T et al. |
The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells. |
2012 |
Biochimie |
pmid:22902867
|
Yamamoto Y et al. |
Synthesis of phosphatidylated-monoterpene alcohols catalyzed by phospholipase D and their antiproliferative effects on human cancer cells. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18556205
|
Cornelissen S et al. |
Whole-cell-based CYP153A6-catalyzed (S)-limonene hydroxylation efficiency depends on host background and profits from monoterpene uptake via AlkL. |
2013 |
Biotechnol. Bioeng. |
pmid:23239244
|
Kim D and Ortiz de Montellano PR |
Tricistronic overexpression of cytochrome P450cam, putidaredoxin, and putidaredoxin reductase provides a useful cell-based catalytic system. |
2009 |
Biotechnol. Lett. |
pmid:19458919
|
Jung HJ et al. |
Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities. |
2012 |
Blood |
pmid:22294726
|
Yuri T et al. |
Perillyl alcohol inhibits human breast cancer cell growth in vitro and in vivo. |
2004 |
Breast Cancer Res. Treat. |
pmid:15026623
|
Murren JR et al. |
Phase I study of perillyl alcohol in patients with refractory malignancies. |
2002 Mar-Apr |
Cancer Biol. Ther. |
pmid:12170772
|
Bailey HH et al. |
A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days. |
2004 |
Cancer Chemother. Pharmacol. |
pmid:15205914
|
Bailey HH et al. |
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. |
2008 |
Cancer Chemother. Pharmacol. |
pmid:17885756
|
Azzoli CG et al. |
A phase I trial of perillyl alcohol in patients with advanced solid tumors. |
2003 |
Cancer Chemother. Pharmacol. |
pmid:12695855
|
Morgan-Meadows S et al. |
Phase I trial of perillyl alcohol administered four times daily continuously. |
2003 |
Cancer Chemother. Pharmacol. |
pmid:12904896
|
Lluria-Prevatt M et al. |
Effects of perillyl alcohol on melanoma in the TPras mouse model. |
2002 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:12050099
|
Yeruva L et al. |
Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells. |
2007 |
Cancer Lett. |
pmid:17888568
|
Chung BH et al. |
Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells. |
2006 |
Cancer Lett. |
pmid:16029925
|
Ren Z and Gould MN |
Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol. |
1994 |
Cancer Lett. |
pmid:8149348
|
Gelb MH et al. |
The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. |
1995 |
Cancer Lett. |
pmid:7767906
|
Shi W and Gould MN |
Induction of differentiation in neuro-2A cells by the monoterpene perillyl alcohol. |
1995 |
Cancer Lett. |
pmid:7656215
|
Stark MJ et al. |
Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. |
1995 |
Cancer Lett. |
pmid:7553603
|
Bardon S et al. |
Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. |
2002 |
Cancer Lett. |
pmid:12175534
|
Stratton SP et al. |
A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer. |
2010 |
Cancer Prev Res (Phila) |
pmid:20103724
|
Clifford JL and DiGiovanni J |
The promise of natural products for blocking early events in skin carcinogenesis. |
2010 |
Cancer Prev Res (Phila) |
pmid:20103730
|